Xrf Scientific Limited · ASX:XRF
Xrf Scientific — Investor Presentation (March 2013)
14 slides from Xrf Scientific's investor presentation, Mar 6, 2013
Slide 1: Investor Presentation March 2013
For personal use only Investor Presentation March 2013
Slide 2: Corporate Snapshot
Corporate Snapshot For personal use only Capital Structure Share Price Performance – 1 Year Shares on issue 132,157,097 $0.40 Options on issue Nil Share price 38c $0.35 Market cap $50.2m (undiluted) $0.30 Cash (28/02/2013) $8.0m (6 cents per share) $0.25 Debt (28/02/2013) $0.0m $0.20 Enterprise Valu
Slide 3: Company Overview
Company Overview For personal use only Manufacturer of consumables and equipment for mining and industry, for X‐Ray Fluorescence (XRF) analysis – a powerful long‐established analytical technique, vital to the discovery, evaluation, qualification and production of most metals (except gold) Office
Slide 4: Our Products
Our Products X‐Ray Flux Platinum Labware Fusion Machines For personal use only Products Industry Samples Shipping Laboratory Samples Exploration Stock & Blend Mining Rail 4
Slide 5: The XRF Analysis Process
The XRF Analysis Process For personal use only Drill core is sent from the field to the laboratory The drill core is then processed into a fine dust The glass disk is presented into an x‐ray spectrometer for analysis The mineral dust is then fused into a glass bead using XRF Scientific’s products 5
Slide 6: Revenue Base
Revenue Base For personal use only Industry Exposure Commodity Exposure (Estimated) 5% 5% Iron Ore Nickel 18% Mining 45% Copper Industry 8% Mineral Sands 5% 19% Other Base Metals 95% Non Mining (Industry) Customers International Sales Miners 25% 28% 30% Commercial International Labs Domestic Others
Slide 7: Results Snapshot
Results Snapshot For personal use only Revenue up 10% on 1H12 EBITDA up 34% on 1H12 NPAT up 39% on 1H12 2.3 13.6 3.5 13.4 12.4 2.0 11.7 2.9 2.7 2.6 1.6 1.6 8.6 1.7 1.0 1H11 2H11 1H12 2H12 1H13 1H11 2H11 1H12 2H12 1H13 1H11 2H11 1H12 2H12 1H13 Sales Revenue ($m) EBITDA ($m) NPAT ($m) 7
Slide 8: Half Year Results – Overview
Half Year Results – Overview For personal use only ($m) 1H13 1H12 Change % Revenue 13.6 12.4 10% EBITDA 3.5 2.6 34% Profit before tax 3.3 2.3 39% Net profit after tax 2.3 1.6 39% Earnings per share (cents) 1.7 1.3 33% Weighted average no. of shares 129,338,832 125,503,805 3% Number of employees 67 6
Slide 9: Consumables
Consumables For personal use only Overview for 1H13: ($m) 1H13 1H12 Sales revenue 3.9 3.6 Revenue up 9% on PCP Change in % 9% 33% NPBT up 21% on PCP Growth in volumes over the PCP NPBT 1.4 1.2 Change in % 21% 46% Outlook for 2H13: Margin % 37% 33% Increased levels of production mining an
Slide 10: Precious Metals
Precious Metals For personal use only Overview for 1H13: ($m) 1H13 1H12 Sales revenue 5.3 5.2 Revenue up 3% on PCP Change in % 3% 44% NPBT up 13% on PCP Strong level of new platinum labware sales NPBT 0.9 0.8 Change in % 13% 45% Outlook for 2H13: Margin % 17% 16% Development of complemen
Slide 11: Capital Equipment
Capital Equipment For personal use only Overview for 1H13: ($m) 1H13 1H12 Sales revenue 5.2 3.9 Revenue up 34% on PCP Change in % 34% 52% NPBT up 155% on PCP Streamlined product offerings, overhead NPBT 0.9 0.3 costs and manufacturing processes Change in % 155% 229% Removal of low margin O
Slide 12: Growth Strategy
Growth Strategy For personal use only Acquisitions: Organic Growth: Criteria Increased volumes in mining Be a business we understand Geographical expansion Have a technology base and barriers to New product releases entry Adoption of XRF as an analytical Strong synergies with our exist
Slide 13: Contact Information
Contact Information For personal use only Tel: (08) 9244 0600 98 Guthrie St. Osborne Park WA Vance Stazzonelli – CEO vance.stazzonelli@xrfscientific.com 13
Slide 14: Disclaimer
Disclaimer For personal use only No responsibility for contents of Investor Presentation •To the maximum extent permitted by law, XRF Scientific Limited and representatives: •make no representation, warranty or undertaking, express or implied, as to the adequacy, accuracy, completeness or reasonable